OBJECTIVE To carry out a meta analysis on the results of all conducted studies to present valid information about the impact of air pollution exposure on the risk of allergic rhinitis in children. METHODS PubMed, Science, Google Scholar and MDPI database were searched up to January 1, 2012 to July 1, 2017, including the observational studies about air pollution and children with allergic rhinitis. Combie cross-sectional study evaluation tool and NOS scale were used to evaluate the quality of literature. The odds ratio of representative air pollutants(NO2, SO2, PM10) exposed to the risk of allergic rhinitis in children and it 95％ confidence interval as effects, and based on the heterogeneity analysis and publication bias test of Review Manager 5.3 software. The effects were analyzed by fixed or random effects model. RESULTS Finally, 6 studies were included in the meta analysis (4 cross-sectional studies, 2 cohort studies). The results showed that exposure to nitrogen dioxide increased the risk of allergic rhinitis(OR=1.22, 95％CI[1.04, 1.42], P=0.01), exposing tosulfur dioxideincreased the risk of allergic rhinitis(OR=1.06, 95％CI[0.96, 1.18], P=0.23), and PM10 increased the risk of allergic rhinitis(OR=1.13, 95％CI[1.04, 1.23], P=0, 004). CONCLUSION Air pollution is a risk factor for allergic rhinitis in children, and the risk of allergic rhinitis will be increase when exposed to NO2 and PM10.

【Objective】 To explore the safety and efficacy of neoadjuvant chemotherapy (NAC) combined with immunotherapy before radical cystectomy plus pelvic lymph nodes dissection (RC-PLND) for muscle-invasive bladder cancer (MIBC). 【Methods】 The clinical data of 101 patients with MIBC who underwent neoadjuvant therapy followed by RC-PLND in the Department of Urology, the First Affiliated Hospital of Xi’an Jiaotong University during Jan.2019 and Dec.2023 were retrospectively analyzed, including 71 patients (70.3%) who received NAC (NAC group) and 30 (29.7%) who received NAC combined with immunotherapy (NAC combine immunotherapy group). The clinical and pathological data and adverse events during neoadjuvant therapy were compared.Logistic regression analysis was used to explore the independent predictors of pathological complete response (pCR) and pathological partial response (pPR). 【Results】 There were no significant differences in the baseline data between the two groups (P>0.05).However, the proportion of multiple tumors in patients receiving NAC before surgery was significantly higher than that in the NAC combined immunotherapy group (69.0% vs. 46.7%, P=0.034).Compared with NAC group, NAC combined with immunotherapy group had significantly improved rate of pathological downstaging and pPR (60.6% vs. 83.3%, P=0.026; 45.1% vs. 70.0%, P=0.022).Furthermore, the rate of pCR in patients undergoing NAC combined immunotherapy was higher than those undergoing NAC, but the difference was not significant (53.3% vs. 33.8%, P=0.067).Logistic regression analysis revealed that clinical T-stage and tumor diameter were independent predictors of pCR and pPR (P<0.05).In addition, the most common adverse events during neoadjuvant therapy were anemia, decreased white blood cells, nausea, and vomiting, but most of them were grade 1—2 and could be relieved through symptomatic treatment. 【Conclusion】 NAC combined with immunotherapy is safe and effective, which can improve the rate of pathological downstaging, pPR and pCR, without increasing the incidence of adverse reactions.